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Abstract
Chromatin proteins provide a scaffold for DNA packaging and a basis for epigenetic regulation and genomic maintenance.
Despite understanding its functional roles, mapping the chromatin proteome (i.e. the ‘‘Chromatome’’) is still a continuing
process. Here, we assess the biological specificity and proteomic extent of three distinct chromatin preparations by
identifying proteins in selected chromatin-enriched fractions using mass spectrometry-based proteomics. These
experiments allowed us to produce a chromatin catalog, including several proteins ranging from highly abundant histone
proteins to less abundant members of different chromatin machinery complexes. Using a Normalized Spectral Abundance
Factor approach, we quantified relative abundances of the proteins across the chromatin enriched fractions giving a
glimpse into their chromosomal abundance. The large-scale data sets also allowed for the discovery of a variety of novel
post-translational modifications on the identified chromatin proteins. With these comparisons, we find one of the probed
methods to be qualitatively superior in specificity for chromatin proteins, but inferior in proteomic extent, evidencing a
compromise that must be made between biological specificity and broadness of characterization. Additionally, we attempt
to identify proteins in eu- and heterochromatin, verifying the enrichments by characterizing the post-translational
modifications detected on histone proteins from these chromatin regions. In summary, our results provide insights into the
value of different methods to extract chromatin-associated proteins and provide starting points to study the factors that
may be involved in directing gene expression and other chromatin-related processes.
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Introduction
Chromatin plays a key role in nearly all eukaryotic DNA
templated processes such as mitosis, DNA repair, and transcrip-
tion. Disruption of chromatin structure is intimately associated
with various human diseases, such as cancer and several congenital
syndromes including a-thalassemia/mental retardation and Ru-
binstein-Taybi syndromes [1,2]. The molecular basis for chroma-
tin function can be understood at level of the nucleosome,
comprised of approximately 146 base pairs of DNA coiling around
an histone octamer conformed by one histone H3–H4 tetramer
and two histone H2A–H2B dimers [3]. Chromatin domains are
formed and maintained by the interaction and post-translational
modification (PTM) of chromatin proteins, which can epigenet-
ically alter gene expression [4,5,6]. Within these domains,
transcriptionally active regions constitute euchromatin, while
transcriptionally inert regions constitute heterochromatin [7,8].
Euchromatin is less condensed, and believed to be more accessible
to transcription factors, whereas heterochromatin is more
condensed and less accessible to the transcriptional machinery
[7]. This epigenetic and structural regulation, along with the
genomic information, has been termed the ‘‘Chromatome’’ [9].
Improved system-wide knowledge of the components of chromatin
could provide a holistic insight into its higher-order structure and
function.
Fully characterizing the chromatome is nontrivial as many
chromatin proteins are expressed transiently, at low levels, or are
difficult to extract from the nucleus [10]. Furthermore, no
purification method has arisen as the ‘‘gold standard’’ for
chromatin extraction. Proteomic techniques have partly circum-
vented these difficulties and considerably accelerated studies on
the chromatin proteomes from various species including Oryza
sativa, Saccharomyces cerevisiae, Xenopus laevis, and Caenorhabitis elegans
[11,12,13,14]. Several mass spectrometry (MS)-based proteomic
studies have also made notable progress in characterizing human
chromatin from mitotic chromosomes [15,16]. In B lymphocytes,
over 280 chromatin proteins were recently identified, however,
with only 64 known to be nuclear, clearly illustrating the technical
issues associated with purifying chromatin fractions [10]. While a
vast number of chromatin proteins has been detected, the total
number of human chromatin proteins, including variants and
isoforms, is likely to be much larger with over 2,000 hypothetical
human genes encoding for transcriptional activators alone [17,18].
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Another layer of chromatome complexity lies in the post-
translational modification (PTM) of chromatin proteins. Several
chromatin proteins are known to be highly modified, such as
Heterochromatin Protein 1 (HP1) and High Mobility Group
(HMG) proteins, where these PTMs may control protein function
and regulate chromatin structure [19,20,21]. Notable among this
broad class of proteins, histone proteins exhibit extensive PTM
patterns including methylation and acetylation at specific residues
[3,22]. Interestingly, histone PTMs are linked to various cellular
events including apoptosis, cellular differentiation, and the cell
cycle [3,23,24]. Specific histone PTMs have been reported to
associate with eu- and heterochromatin, and coexisting PTMs
form and maintain those regions [25,26,27]. The diversity and
specificity associated with histone PTMs has led to the ‘Histone
Code’ hypothesis, which proposes that PTMs act as binding sites
for other chromatin proteins that ‘‘interpret’’ these modifications
to regulate DNA-templated processes [22,28,29]. Quantifying the
full collection of histone PTMs involved in euchromatin and
heterochromatin maintenance therefore may illuminate down-
stream and upstream mechanisms governing these genomic
regions.
Here we present a large-scale proteomic mass spectrometry-
based comparison of three selected chromatin extraction methods.
Proteins enriched in each preparation were analyzed via a Bottom
Up mass spectrometry based proteomics approach including
separation by one-dimensional gel electrophoresis (1D-SDS-
PAGE), in-gel tryptic digestion, and nanoflow LC-MS/MS
performed in a high-resolution Orbitrap mass spectrometer. Our
results indicate that, depending on the downstream application, a
decision between biological specificity and broadness of charac-
terization must be made in selecting a chromatin purification
method. By way of this qualitative comparison, we also achieve an
extensive proteomic catalog of human chromatin. This platform
identified over 1,900 unique proteins from these fractions, the
majority of which are annotated as nuclear proteins. We analyzed
our datasets using a Normalized Spectral Abundance Factor
(NSAF) approach to obtain a relative protein abundance profile
and also detected numerous PTMs in our datasets, including
acetylation, mono-, di- and trimethylation of lysines and arginine
methylation [30]. Moreover, we attempted to carry out proteomic
investigations into euchromatin- and heterochromatin-enriched
fractions and identified proteins seemingly enriched in either
fraction. To corroborate the enrichment for these genomic
regions, we also characterized histone PTMs in the euchromatin
or heterochromatin enriched samples using a stable isotope
labeling quantitative MS method. We hope our findings will act
as a foundation for additional studies involving the higher-level
structure of chromatin and its roles in basal or aberrant gene
functions during dynamic or epigenetic processes.
Materials and Methods
All chemicals and reagents were purchased from Sigma Aldrich
(St. Louis, MO) unless otherwise noted.
Cell Culture
HeLa S3 cells were grown and harvested as previously described
[31].
Total Chromatin Extraction
Chromatin was isolated as described with the following
modifications [10,32]. Cells were resuspended in Buffer A
(10 mM HEPES pH=7.9, 10 mM KCl, 1.5 mM MgCl2, 0.34 M
sucrose, 10% glycerol, inhibitor cocktail: 1 mM DTT, 0.5 mM 4-
(2-aminoethyl) benzenesulfonyl fluoride hydrochloride, 5 mM
microcystin and 10 mM sodium butyrate). Triton X-100 was
added to a final concentration of 0.1% and the suspension was
incubated for 8 minutes on ice. The nuclear pellet was obtained by
centrifugation (1,3006g for 5 minutes at 4uC), washed with Buffer
A and then resuspended in Buffer B (3 mM EDTA, 0.2 mM
EGTA, inhibitor cocktail) for 30 minutes on ice. The insoluble
chromatin pellet was isolated by centrifugation (1,7006 g for
5 minutes at 4uC) and then resuspended in 15 mM Tris, pH=7.5,
0.5% SDS.
Salt Extraction of Chromatin
Cells were resuspended in hypotonic lysis buffer (10 mM
HEPES/KOH pH=7.9, 1.5 mM MgCl2, 10 mM KCl and
inhibitor cocktail) and incubated on ice for 30 minutes. Nuclei
were isolated by centrifugation (4,000 rpm for 10 minutes at 4uC),
and the supernatant was discarded. The nuclear pellet was
resuspended in high salt buffer (20 mM HEPES/KOH pH=7.9,
25% glycerol, 420 mM KCl, 1.5 mM MgCl2, 0.2 mM EDTA,
and inhibitor cocktail) and sonicated for 30 seconds (3610 s) on
ice. The suspension was rotated at 4uC for 2 hours and then
centrifuged (4,000 rpm for 20 minutes at 4uC). The salt
concentration of the supernatant was lowered through a 5-fold
dilution with minimal-salt buffer (20 mM HEPES/KOH
pH=7.9, 25% glycerol, 1.5 mM MgCl2, 0.2 mM EDTA and
protease inhibitors). The pellet was resuspended and dialyzed
overnight at 4uC against minimal-salt buffer in a Slide-A-LyzerH
Dialysis Cassette (Pierce Biotechnology, Rockford, IL).
Chromatin Extraction through Micrococcal Nuclease
Digestion
Nuclei were isolated as previously described [33]. Briefly, cells
were lysed in Nuclear Isolation Buffer (NIB, 15 mM Tris pH=7.5,
15 mM NaCl, 60 mMKCl, 5 mMMgCl2, 1 mM CaCl2, 250 mM
sucrose and inhibitor cocktail) supplemented with 0.3% NP-40
(Calbiochem, EMD Biosciences, La Jolla, CA). The resulting nuclei
pellet was separated by centrifugation (6006g for 5 minutes at 4uC)
and washed twice with NIB. Micrococcal nuclease (MNase)
digestion was performed as described with the following modifica-
tions [34]. Nuclei were resuspended in NIB to a concentration of
approximately 107 nuclei/mL and then preincubated at 37uC for
10 minutes. MNase was added to a final concentration of 5 units/
mL. The digestion proceeded at 37uC for 20 minutes with
occasional mixing, and quenched with 50 mM EDTA. Finally,
the sample was centrifuged at full speed in a tabletop microcen-
trifuge at 4uC for 10 minutes to obtain a supernatant and a pellet.
Euchromatin and Heterochromatin Extraction through
Partial MNase Digestion
Chromatin was isolated as described before with minor changes
[35]. Micrococcal nuclease was added to a final concentration of
1.2 units/mL, and the reaction was quenched by 1 mM EGTA on
ice for 10 minutes. The sample was centrifuged at 1,0006 g for
5 minutes at 4uC to generate the first supernatant (S1). The pellet
was resuspended in 2 mM EDTA at pH=7.2 in the same volume
as S1 and incubated on ice for 10 minutes. The sample was then
centrifuged at 12,0006g at 4uC to yield a second supernatant (S2)
and a pellet. Resulting fractions were loaded onto a 12% SDS
polyacrylamide gel (SDS-PAGE).
In-Gel Digestion of Chromatin Proteins
Approximately 100 mg of extract from each fraction was
resolved on a 12% SDS-PAGE gel. Each lane was cut into 10
Proteomic Analysis of Chromatin
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slices containing approximately the same amount of protein by
visual inspection. In-gel digestion was performed according to the
protocol described previously with minor modifications [36]. Each
sample was desalted on a C18 StageTip prior to MS [37].
Extraction of DNA
DNA was isolated from chromatin samples by chloroform/
phenol extraction as described previously [38]. The DNA was
ethanol-precipitated and then resuspended in water and loaded
onto a 2% agarose gel.
Histone Extraction and Separation
Histones were extracted from S1 and S2 fractions with 0.4N
H2SO4 and precipitated with trichloroacetic acid (TCA), followed
by washes with acetone+0.1% HCl and then acetone [33]. Bulk
histones were redissolved in water and fractionated on a C18
column (4.6 mm i.d.6250 mm, Vydac) using an Beckman Coulter
System Gold HPLC (Fullerton, CA) with a gradient of 30–60% B
in 100 min, followed by 60–100%B in 20 min (A=5% acetonitrile
(MeCN) in 0.2% trifluoracetic acid (TFA), B=90% MeCN in
0.188% TFA) [39]. Fractions were dried to completion in a
vacuum centrifuge and checked for purity by 15% SDS-PAGE.
Histone Preparation for Bottom Up MS
HPLC purified histone variants (,5 mg) were derivatized with
propionyl anhydride as described before [40]. For quantification
studies, either the euchromatic or heterochromatic histones were
labeled using d10-propionic anhydride both before and after
trypsin digestion to introduce a +5Da mass shift (Cambridge
Isotope Laboratories, Andover, MA) [41]. For comparative MS
analysis, protein concentrations of each sample were determined
using Bradford reagent to ensure equal mixing.
NanoLC-MS/MS
Peptides were eluted from C18 Stage Tips using 75% MeCN,
5% acetic acid; the acetonitrile was subsequently evaporated
through vacuum centrifugation [37]. All MS experiments were
performed in the following manner. Peptides were loaded by an
Eksigent AS-2 autosampler (Eksigent Technologies, Dublin, CA)
onto a fused silica microcapillary (75 mm) column packed in-house
with 5 mm C18 YMC ODS-A resin constructed with an integrated
ESI tip. Loaded peptides were HPLC separated with an Agilent
1200 series binary pump across a 150-min linear gradient ranging
from 2% to 35% buffer B (Buffer A= 0.1 M acetic acid, Buffer
B= 70% MeCN in 0.1 M acetic acid) with a flow of 100–200 nL/
min. For histones, a 110-min gradient was used. The HPLC was
coupled to an LTQ-Orbitrap mass spectrometer (ThermoFisher
Scientific, Waltham, MA). Full MS spectra (m/z 300–1650) were
acquired in the Orbitrap with a resolution of 30,000 at m/z 400
after accumulation of 500,000 ions. The seven most intense ions
were sequenced by collision-induced dissociation (normalized
collision energy 35%) in the LTQ after accumulation of 10,000
ions concurrently to full scan acquisition in the Orbitrap. Maximal
filling time was 500 ms for the full scans. Precursor ion charge
state screening was enabled and all unassigned charge states as
well as singly charged species were rejected. The dynamic
exclusion list was restricted to a maximum of 500 entries with a
maximum retention period of 120 seconds and a relative mass
window of ,1 Da.
Data Analysis
Mass spectra were searched using the SEQUEST algorithm
within the Bioworks Browser (Version 3.3.1 SP1, Thermo Fisher
Scientific) against the National Center for Biotechnology Infor-
mation (NCBI) human protein database. Three missed cleavage
sites were allowed. Peptide tolerance was set to 0.1 Da and
fragment ion tolerance was set to 0.5 Da. Carboxyamidomethyla-
tion on cysteine (+57.021) was set as a fixed modification, while
oxidation of methionine (+15.999) was set as a variable
modification. For PTM searches, acetylation (+42.010 Da), mono-
(+14.016 Da), di- (+28.031 Da) and trimethylation (+42.046 Da)
of lysine residues, mono (+14.016 Da) and dimethylation
(+28.031 Da) of arginine residues, and N-terminal acetylation
(+42.010 Da) were selected as variable modifications. Resulting
peptides were filtered using criteria as previously described, such as
Xcorr values of 2, 2.5, and 3 for charge states of 2, 3, and 4
respectively [42]. Protein matches with a probability higher than
561023 were not considered. The false positive rate was estimated
to be the 1% level by searching a reverse database as previously
stated [43].
To quantify relative protein abundance, we calculated the
Normalized Spectral Abundance Factor (NSAF) for each protein.
We developed a script in Matlab R2007b (Version 7.5.0.342,
August 2007, The MathWorks, Inc.) that counts the number of
tandem mass spectra for a given protein and obtains the
information to calculate spectral abundance as previously
published. Proteins identified from only a single MS/MS spectrum
were discarded. For euchromatin and heterochromatin analysis,
only proteins found multiple times in biological and technical
replicates were included in the results. Functional annotation for
more than 80% of the identified proteins was carried out with the
online tool DAVID Bioinformatic Resources 2008 (http://david.
abcc.ncifcrf.gov/) [44,45,46]. Default settings in DAVID’s func-
tional annotation tool were used to search each dataset. For
histone PTM determination, spectra were manually analyzed.
Fold change was calculated by taking the abundance of a given
modification in euchromatin and dividing it over the abundance of
the same modification in heterochromatin. A fold change higher
than 1 would indicate enrichment for the modification in
euchromatin, while a fold change lower than 1 would indicate
enrichment for the modification in heterochromatin. Heat maps
depicting the ratio of histone PTMs in euchromatin over
heterochromatin were created by using Java Treeview and Matlab
[47]. Fisher’s exact test was performed to determine the statistical
significance associated with the enrichment of euchromatic and
heterochromatic histone PTMs collectively in the S1 and S2
fractions, respectively.
Results and Discussion
Large-scale proteomic analyses of chromatin enriched
protein fractions
To compare some preparations for chromatin-associated
proteins, we extracted chromatin from HeLa S3 cells using a
total chromatin extraction, a salt extraction and a total
micrococcal (MNase) digestion as shown in Figure 1a, with the
expectation that we would possibly detect slightly different subsets
of chromatin proteins between the three methods. As shown by
1D-SDS-PAGE, each preparation enriched for different chroma-
tin proteins (Figure 1b). We then analyzed the resulting
chromatin samples (two technical replicates) from all three
methods using mass spectrometry reporting only the proteins
detected in both technical replicates. Through these analyses we
found a total of over 77,000 peptides matching to 1,038 non-
redundant proteins in the total chromatin extraction, 1,388
proteins in the salt extraction method (supernatant and pellet
combined) and 949 proteins in the total MNase digestion method
Proteomic Analysis of Chromatin
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(supernatant and pellet combined, Data S1). All in all, these hits
correspond to a total of 1,912 unique proteins in these chromatin
enriched fractions including 193 previously uncharacterized
(‘‘hypothetical’’ or ‘‘predicted’’) proteins (Figure 1c, and Data
S1). In this report, a unique protein is a protein hit assigned an
NCBI annotation number; thus, protein isoforms and protein
complexes subunits are considered distinct. Approximately 25% of
the proteins (487 hits) were purified across all three methods, while
roughly half of the protein total seemed exclusive to a single
preparation (Figure 1c). 261 of the proteins found in our screen
were also listed in the chromatin database ChromDB which
contains a total of 408 human chromatin proteins mapping to 466
protein accession numbers [48].
Over 30% of the proteins detected in all three data sets
correspond to annotated nuclear proteins, while less than 10% are
cytosolic. Fewer than 20%, 10%, and 5% of the non-nuclear
proteins were annotated as mitochondrial, ribosomal and
cytoskeletal respectively (Figure 2a). Almost 45% of the proteins
identified in the total MNase digestion fraction are classified as
nuclear, while lower percentages were observed in the other two
preparations (Figure 2a). Uniquely, the MNase digestion
detected known chromatin components of lower abundance such
as Aurora Kinase B, SUV39H1 and other chromatin modifying
proteins (Table 1 and Data S2). The total extraction method
identified fewer proteins than the salt extraction method, but was
more specific for chromatin proteins (Figure 2a). Approximately
15% of the proteins found in each preparation could not be
annotated, which is likely attributed to proteins with unknown or
multiple cellular localizations (Figure 2a). We also examined the
functional annotation of the identified proteins (Figure 2b). As
Figure 1. Comparison between chromatin purification methods. (a.) Chromatin was purified from HeLa cells through three different
preparations. (b.) SDS-PAGE analysis of a crude nuclear lysate and the chromatin preparations. Approximately 10 ug of protein were loaded in each
lane. Supernatant and pellet fractions are shown separately for the salt extraction and the MNase digestion protocols. (c.) Venn Diagram indicating
the number of proteins detected in one, two or all three chromatin preparations. Where applicable, preparation fractions (supernatant and pellet)
were combined.
doi:10.1371/journal.pone.0024747.g001
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Figure 2. Classification of proteins identified in chromatin preparations. This was accomplished according to (a.) their cellular location and
(b.) their functional categorization. The white column corresponds to the total extraction of chromatin, while gray and black columns correspond to
the salt extraction and total digestion of chromatin respectively. Preparation fractions (supernatant and pellet) were combined where applicable.
Protein quantity refers to the percentage of proteins in each category with respect to the total number proteins found in each particular preparation.
doi:10.1371/journal.pone.0024747.g002
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expected, most proteins were involved in DNA processes, such as
gene expression and nucleic acid biology. We also found proteins
involved in biological events, such as DNA repair and apoptosis
(Figure 2b). In agreement with our cellular localization data, the
total chromatin extraction and the MNase digestion preparation
have the highest proportion of proteins involved in chromatin
processes (Figure 2b), with the MNase procedure demonstrating
higher specificity for chromatin proteins. We believe that this is
due to the utilization of a biological property of the target proteins,
i.e. its association with DNA, rather than a nonspecific physical
property, such as solubility. However, it is important to note that
no protein annotation approach should be taken without caution.
Namely, an issue with categorizing proteins is that a large number
of proteins have multiple assigned cellular localization or function,
and hence results are mixed or at best diluted.
To semi-quantitatively measure the relative abundance of the
identified proteins, we used a Normalized Spectral Abundance
Factor (NSAF) approach [30]. Not surprisingly, we found the most
abundant proteins in the total chromatin extraction included the
four core histones (H2A, H2B, H3 and H4) and H1 (Table 1,
Data S2 and Figure S1). We detect the histone proteins among
the most prevalent hits across all three methods. These findings
make much sense as core and linker histone proteins are estimated
to constitute approximately 70% of chromatin [16]. Other
predominant proteins present in our dataset include heterochro-
matin protein 1 (HP1), high mobility group (HMG) proteins, and
RNA polymerase II, all well-characterized nuclear proteins (Data
S2). While RNA polymerase II is involved in DNA transcription
[49], HP1 and HMG proteins are involved in regulating
chromatin structure and accessibility: HP1 binds histone H3
methylated at Lys 9 and promotes gene silencing and heterochro-
matin formation [8] and HMG proteins associate with nucleo-
somes to modulate specific gene expression [50].
We also identified proteins involved in DNA methylation such
as Cytosine-5-methyl-transferases, in DNA damage recognition
such as DNA damage binding protein 1, in binding specific histone
Table 1. Relative quantification for selected chromatin-enriched proteins.
Normalized Spectral Abundance Factor
Protein
Total
Extraction
Salt Extraction
Sup.
Salt Extraction
Pellet
MNase
Dig. Sup.
MNase
Dig. Pellet
H1 1.5E-02 9.2E-03 2.6E-02 5.6E-03 2.1E-02
H2A 3.5E-02 1.1E-02 2.0E-02 2.0E-02 1.8E-02
H3 2.3E-02 2.9E-03 1.0E-02 4.2E-03 1.1E-02
H4 3.6E-02 1.2E-02 2.9E-02 2.2E-02 3.4E-02
H2B 2.8E-02 6.3E-03 1.8E-02 1.4E-02 2.7E-02
Core histone macroH2A2.2 1.4E-03 n/d1 n/d 7.7E-04 1.7E-04
HP1 alpha 9.2E-04 4.2E-04 2.0E-03 1.7E-03 8.5E-04
HP1 beta 4.3E-04 1.1E-03 2.2E-03 9.0E-03 1.6E-03
HP1 gamma 8.2E-04 2.9E-04 1.4E-03 3.4E-03 1.6E-03
Histone deacetylase 1 1.8E-04 n/d 2.4E-04 n/d 6.1E-04
Histone deacetylase 2 1.4E-04 1.8E-04 n/d 4.9E-04 3.3E-04
chromatin-specific transcription elongation
factor large subunit
2.9E-04 3.5E-04 1.8E-04 5.9E-04 1.6E-03
general transcription factor II, isoform 3 1.9E-04 3.8E-04 n/d n/d n/d
SWI/SNF-related matrix-associated actin-dependent
regulator of chromatin
8.4E-05 n/d n/d 7.24E-04 1.6E-03
chromatin assembly factor 1 subunit B 7.9E-05 n/d n/d 2.6E-04 n/d
upstream binding transcription factor,
RNA polymerase I isoform b
4.8E-05 2.6E-04 n/d n/d 4.4E-04
transcription factor MAFF 1.1E-04 n/d n/d n/d n/d
transcription factor ELYS 7.8E-06 n/d n/d n/d 1.0E-04
general transcription factor IIF, polypeptide 2 (30kD subunit) n/d 5.3E-04 n/d n/d n/d
DNA (cytosine-5-)-methyltransferase 1 6.5E-05 4.9E-05 n/d 8.8E-05 n/d
O-6-methylguanine-DNA methyltransferase 2.1E-04 5.1E-04 n/d n/d n/d
chromatin accessibility complex 1 n/d n/d 2.9E-04 n/d n/d
suppressor of variegation 3–9 homolog1 n/d n/d n/d n/d 3.9E-04
centromere protein F (350/400kD) n/d n/d n/d 4.6E-05 n/d
chromatin modifying protein 4B n/d n/d n/d n/d 8.7E-04
chromatin modifying protein 4A n/d n/d n/d n/d 2.4E-04
Aurora kinase B n/d n/d n/d 6.9E-04 4.7E-04
DNA directed RNA polymerase II polypeptide E 2.9E-04 5.0E-04 5.4E-04 1.1E-03 6.1E-04
1Not detected.
doi:10.1371/journal.pone.0024747.t001
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PTMs such as bromo- and chromo-domain containing proteins,
and in modifying histones, such as the enzymes poly-ADP ribose
polymerase and HDACs (Data S2). As it is common in this type of
large-scale survey analysis, we also detect proteins that are
improbable chromatin proteins and more likely to be contami-
nants. The presence of non-nuclear proteins is inevitable due to
their greater abundance relative to chromatin proteins. Interest-
ingly, among the most abundant proteins extracted were actin and
vimentin, proteins which have been traditionally considered to be
cytoskeletal. However, recent evidence points towards their
potential functional involvement in the nucleus. Actin has been
demonstrated to be involved in chromatin remodeling and gene
repositioning in the nucleus [51,52]. Vimentin has been shown to
bind DNA and has also been suggested to be involved in gene
regulation events [53]. Therefore, with this data we cannot
completely rule out normally classified cytoplasmic proteins as
having a dual role in nuclear events, though further experimental
validation is needed to definitely assign a nuclear function.
Post-translational modifications on chromatin enriched
proteins
To characterize post-translational modifications (PTMs) on
chromatin associated proteins, we examined our total chromatin
datasets using the SEQUEST algorithm and modified peptides are
listed in Data S3. All chromatin preparations preserved PTMs to
a comparable degree. We confirmed several well documented
cases of lysine and arginine methylation on histones H2A, H2B,
H3, H4 and H1 and lysine methylation on HP1 [20], as well as
potentially discovering novel modifications. For example, we
detected dimethylation on R480 of TATA-binding protein-
associated factor (TAF) 2N isoform 2, and to the best of our
knowledge, this represents a novel assignment (Figure 3). Other
sites of modification on the same protein include dimethylation of
R203, R525, R532, R567, and monomethylation on R559 (Data
S3). A previous proteomics study also identified R203me2 in the
same cell line used in our study, corroborating our findings [54].
Overall, we found 45 proteins containing arginine mono- or
dimethylation, 85 proteins containing lysine formylation, mono-,
di-, or trimethylation, and 110 proteins containing lysine or N-
terminal acetylation. Within the aforementioned classes, we found
over 90, 155, and 130 unique post-translationally modified
peptides, respectively. Since the number of modified peptides
exceeds the number of modified proteins, several proteins contain
multiple modification types and/or modified residues, such as the
previously mentioned TAF2N. We excluded all C-terminally
monomethylated peptides from our results, which may originate
from an acid-catalyzed reaction between the C-terminus of the
tryptic peptide and methanol in the sample preparation [55].
Although we chose to err on the rigorous side, this exclusion also
means that our list probably underestimates the actual in vivo list of
monomethylated proteins. Other higher degrees of methylation, as
well as formylation and acetylation on C-terminal residues were
included, as there is no facile explanation for their generation by
protocol-induced chemical means, and they have been previously
shown to be able to be cleaved by trypsin under prolonged
digestion [56,57]. Given that over 10% of the proteins identified
between the three methods contain at least one PTM, it is likely
that the PTMs serve specific chromatin biology function, possibly
Figure 3. Post-translational modification of a chromatin-associated protein. MS/MS spectrum of the [M+2H]2+ precursor ion of TAF 2N
isoform 2 (473–487 residue peptide) dimethylated on R480. Broken bonds above and below sequence denote b and y ions, respectively, that were
annotated from the spectrum.
doi:10.1371/journal.pone.0024747.g003
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to regulate protein stability, conformation, localization, and
interaction with DNA or other proteins [21,51]. The last
possibility is especially intriguing for TAF 2N isoform 2, where
arginine methylation may influence the binding of TATA binding
protein, TFIID complex or RNA polymerase II during initiation
of transcription [58]. Further experiments, such as site-directed
mutagenesis combined with functional readout, are needed to
determine the significance of these modifications.
Proteomics of euchromatin and heterochromatin
enriched fractions
To further assess the potential of the MNase purification
method and continue to define the profile of chromatin proteins,
we attempted to identify proteins enriched in crude euchromatin
and heterochromatin subfractions. MNase has long been used to
study the structural differences in packaging between these two
classes of chromatin, where euchromatin is more accessible to
MNase digestion than heterochromatin [59]. Attempting to
exploit this feature, we tried to separate euchromatin and
heterochromatin in the S1 and S2 supernatants, respectively,
resulting from a limited MNase digestion (Figure 4a) [35]. This
MNase preparation also yields a pellet fraction that is thought to
be enriched in ‘matrix’-containing chromatin [38,60]. As shown
by SDS-PAGE, S1, S2 and the pellet fractions were enriched in
different chromatin proteins (Figure 4b). As expected, euchro-
matin was mostly digested to mononucleosomes, while hetero-
Figure 4. Crude separation of euchromatin and heterochromatin. (a.) Purification diagram, (b.) One-dimensional SDS-PAGE analysis of
euchromatin (S1), heterochromatin (S2) and pellet fractions. Proteins in these fractions were separated by one-dimensional 15% SDS-PAGE gel and
stained with Coomassie Brilliant Blue. Loading is approximately 10 ug of protein per lane, (c.) DNA gel (2% agarose) of S1, S2, and pellet fractions. S1 is
composed mostly of mononucleosomes running at approximately 150 bp (black arrow). S2 and pellet fractions contain longer pieces of DNA
corresponding to more compact chromatin. Total MNase digestion is shown for comparison, (d.) Venn Diagram indicating the number of proteins
detected in one, two or all three fractions.
doi:10.1371/journal.pone.0024747.g004
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chromatin was digested into larger DNA oligomers (Figure 4c),
consistent with a more open euchromatin structure. DNA in the
pellet remained in even larger fragments (Figure 4c).
To identify the chromatin proteins in the euchromatin or
heterochromatin fractions, we analyzed two biological replicates of
the S1, S2 and pellet fractions using MS, reporting only proteins
detected in both biological replicates. We found a total of 751
unique proteins between all three fractions, where the majority
(691 proteins) were also found in our total chromatin surveys. Out
of the 530, 384, and 269 proteins in the euchromatin,
heterochromatin, and pellet fractions respectively, 274 and 103
were detected only in euchromatin and heterochromatin respec-
tively, following subtractive analysis. There were 228 proteins
shared between euchromatin and heterochromatin (Figure 4d).
As before, the majority of the proteins identified in all three
fractions correspond to nuclear proteins, while less than 15% are
categorized as cytosolic, mitochondrial, ribosomal and cytoskeletal
(data not shown). We again found that approximately 15% of the
proteins found in each fraction could not be annotated.
Interestingly, we found that the pellet fractions have a higher
percentage of cytosolic and mitochondrial proteins than the S1 and
S2 fractions while it also has a lower amount of non-annotated
proteins. As we did for the total chromatin analysis, we checked
the functional annotation and categorization of the identified
proteins (Figure 5). The largest groups of proteins in all fractions
are involved in DNA processes, such as gene expression, nucleic
acid binding and their metabolic processes. We find the pellet is
less enriched in these proteins than euchromatin and heterochro-
matin fractions.
Among the proteins found enriched in the euchromatin fraction
following subtractive analysis, we found TAF 2N isoform 2 whose
biological function is consistent with this finding (Data S4). In the
heterochromatin enriched fraction, we found proteins such as
Aurora B kinase, which has a role in marking silent chromatin
through phosphorylation of H3S10 [27,61]. Among the proteins
detected in both euchromatin and heterochromatin is the DEK
oncogene product (Data S4). DEK is an abundant and ubiquitous
chromatin protein, which preferentially binds to superhelical and
cruciform DNA, and induces positive supercoils into closed
circular DNA, and has been suggested to function as an
architectural protein in chromatin, akin to HMG proteins [62].
We should note that these preparations are very crude
biochemical fractionation methods, and the large overlap of
proteins between fractions is presumably due to euchromatin
fractions being potentially contaminated with the more abundant
heterochromatin portion. Nevertheless, these results seem fairly
reproducible through biological replicates. Interestingly, recent
results do demonstrate the possibility of overlap of euchromatic
Figure 5. Functional categorization of euchromatin and heterochromatin proteins. The white column corresponds to euchromatin, while
the gray and black columns correspond to heterochromatin and matrix-associated chromatin respectively. Protein quantity refers to the percentage
of proteins in each category with respect to the total number proteins found in each particular fraction.
doi:10.1371/journal.pone.0024747.g005
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and heterochromatic components and chromatin modifications
including RNA Polymerase II complex members [49,63,64,65],
thus several proteins may be present (but not necessarily active) in
both chromatin regions.
Global histone codes enriched in euchromatin and
heterochromatin fractions
Histones are a major protein component of chromatin, and thus
we aimed to validate our crude biochemical separation of
euchromatin and heterochromatin by characterizing the abundant
PTMs on histone H3 variants and H4 from the euchromatic and
heterochromatic enriched fractions using quantitative mass
spectrometry (Figure S2). We chose to analyze the H3 variants
separately because each may be correlated with different
transcriptional states, as recently shown by the genomic analysis
of the location of mammalian H3 variants [66]. For quantitative
investigations of the potential PTM differences amongst the H3
variants, we turned to using a chemical derivatization approach
that incorporates stable isotopic labeling onto the histone peptides
[43]. Specifically, light (d0) and heavy (d10) propionic anhydride
Figure 6. Quantitative comparison of selected histone PTMs in euchromatin (d0-labeled) and heterochromatin (d5-labeled). (a.) Full
mass spectrum for the 2+ charge state of an intrinsically unmodified H3.1 peptide (aa 41–49), (b.) Full mass spectrum for the 2+ charge state of a
monoacetylated H3.1 peptide (aa 18–26, H3K18), (c.) Full mass spectrum for the 3+ charge state of the H3.1 dimethylated peptide (aa 27–40, H3K36),
(d.) Full mass spectrum for the 2+ charge state of a diacetylated H4 peptide (aa 4–17) Labels specify the fraction represented by each peak.m/z values
are indicated for each peak.
doi:10.1371/journal.pone.0024747.g006
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are used to isotopically label peptides from two samples for relative
quantification between the samples. In these experiments, we label
peptides from histone H3 extracted from euchromatin with one
isotopic label, and histone H3 peptides from heterochromatin with
the other isotopic label (two biological replicates). An example of
these experiments with peptides from histone H3.1 and H4 is
shown in Figure 6. The [M+2H]2+ ion from the H3 41–49
peptide (YRPGTVALR), which we do not observe to be modified,
can be used to gauge equal loading between samples (Figure 6a).
As expected, histone H3 acetylation levels are enriched in the
euchromatin samples, as previously shown from Drosophila
chromatin [66]. This can be visualized in Figure 6b with
H3K18 acetylation levels on the 18–26 doubly charged peptide,
KQLATKAAR. This particular modification has been described
to mainly reside in the region surrounding transcription start sites
[67]. Some marks were discovered to be enriched in heterochro-
matin samples, as is revealed in Figure 6c for the [M+3H]3+ ion
peptide corresponding to H3K36me2 (KSAPATGGVKKPHR).
The function of mono- and dimethylation of lysine residues on
histones is not well understood compared to the role of lysine
trimethylation. Therefore, our data on many of these marks such
as the H3K36me2 may help elucidate their role in chromatin. We
used this labeling to observe the differential expression of histone
marks between euchromatin (i.e. labeled with d0) and heterochro-
matin (i.e. labeled with d10), and verified the trends by performing
reverse labeling of the two fractions, with results for histone H3
and H4 presented in Figure 7.
Our quantitative proteomics analyses found that monoacetyla-
tion of H3K9, H3K18 (i.e. H3K18ac1K23un), and H3K23 (i.e.
H3K18unK23ac) seems to be increased in euchromatin, while
dimethylation of H3 on K36 is increased in heterochromatin not
only in for the H3.1 variant (Figure 6), but also for all H3 variants
(Figure 7a). Additionally, H3K36me3 is more abundant in
euchromatin, while H3K27me3 is more abundant in heterochro-
matin (Figure 7a). Again, these trends are consistent with current
knowledge on the epigenetic function of these PTMs, where
H3K36me3 is associated with transcriptional elongation and
activation while H3K27me3 is associated with transcriptional
silencing [68]. In addition, there does seem to be some variant
specific differences in the expression of certain PTMs. For
example, trimethylation on H3K9 is decreased in euchromatin
for H3.1 and H3.2 compared to H3.3. This K9 modification is
widely regarded as a heterochromatic/silencing mark, and thus it
is not surprising for it to be decreased on these variants from
genomic regions containing potentially more active genes [69].
Similarly, H3K4me1 is slightly increased in heterochromatin
enriched H3.3; this is consistent with a report that monomethyla-
tion of K4 is a mark for silenced euchromatin [70]. In theory, it
Figure 7. Heat map depicting the ratio of histone H3 and H4 PTMs abundances in euchromatin relative to heterochromatin. Heat
maps for histone variants H3.1, H3.2 and H3.3 (a.) and histone H4 (b.). The scale indicates the fold change between a given PTM abundance in
euchromatin versus heterochromatin. Red indicates an enrichment of a given PTM in euchromatic regions while green corresponds to enrichment in
heterochromatin.
doi:10.1371/journal.pone.0024747.g007
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could be possible that H3K4me1 would become a mark in
heterochromatin as silenced euchromatin becomes part of it.
H3K27me1 and H3K9me1 are more enriched on the H3.2
variant extracted from heterochromatin samples. The unmodified
K27 and K36 states are enriched on H3.2 from euchromatin, but
are decreased slightly in euchromatic H3.3, whereas H3K36me1
levels only seem to decrease on H3.1 in euchromatin. In short,
enrichment for most heterochromatic marks appears to be more
pronounced for H3.2 than for H3.1 or H3.3. These results support
our separation of euchromatin and heterochromatin, while
potentially supporting the H3 ‘‘barcode model’’ which postulates
that histone H3.1 localizes to constitutive heterochromatin,
histone H3.2 to facultative heterochromatin, and H3.3 to
euchromatin [71]. However, when we classified these modifica-
tions based on their epigenetic function and determined the
probability that gene activating- or silencing-associated modifica-
tions are more significantly enriched in the euchromatic or
heterochromatic preparations, we found that the H3 variant data
did not reach statistical significance (p.0.05).
Our mass spectrometric analysis of histone H4 from the
different genomic samples also found all-acetylated forms of H4
to be enriched in euchromatin, particularly di and tri-acetyl
(Figure 6d and Figure 7b). This result is expected since histone
acetylation has been long correlated with transcriptional activation
[72]. We also found that mono-acetylation occurs mostly on K16,
di-acetylation occurs primarily on K12 and K16 while tri-
acetylation occurs on residues K8, K12 and K16 (data not
shown). These experiments also revealed monomethylation of K20
to be slightly enriched in euchromatin, whereas trimethylation on
K20 to be slightly increased in heterochromatin (Figure 7b).
When we classify the H4 modifications based on their epigenetic
function, namely gene activation or silencing, we found that the
gene activating PTMs (i.e. all acetylation states, H4K20me1) and
silencing PTMs (i.e. H4K20me2, H4K20me3) were significantly
enriched in the S1 and S2 fractions respectively (df=1, p=0.0476).
Altogether, we find some histone PTMs to be enriched in
euchromatic and heterochromatic regions and at the same time we
also find that there is some overlap in the histone codes of these
domains. This suggests that gene activation or silencing may not
be constituted by discrete on/off states in terms of histone PTM
patterns, and that combinations of histone PTMs may play a
larger role in modulating transcriptional states than any single
modification alone.
Conclusion
To define the biological specificity and proteomic extent of
three distinct chromatin preparations, we characterized their
resulting protein fractions using MS-based proteomics. Our results
demonstrate the fact that a decision between biological specificity
and broadness of characterization must be made in selecting a
chromatin purification method. By way of this analysis, we have
also contributed information towards the annotation of the human
Chromatome. We identified over 1,900 proteins in the chromatin
preparations (counting contaminant proteins), including 193
previously uncharacterized proteins. Our list of results includes
highly abundant proteins, such as histones, and lower abundance
proteins including histone modifying enzymes and transcription
factors. A large proportion of the proteins are known to be
involved in DNA templated processes, such as DNA repair and
gene regulation. Furthermore, a significant amount of the proteins,
including non-histones were also identified as being covalently
modified with modifications such as methylation and acetylation.
We also crudely separated eu- and heterochromatic protein sub-
fractions and corroborated this separation through the parallel
quantitative analysis of histone PTMs. In addition to providing
new information on the particulars of different chromatin
purification methods, we believe this work may pave the way for
new discoveries involving the higher-order structure and function
of chromatin.
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